The investigators aim to investigate how individuals attending primary healthcare (PHC) services in Brazil for treatment of non-communicable diseases (NCDs), identified there as having abnormal spirometry or as being at high risk for lung health problems (such as asthma and chronic obstructive pulmonary disease-COPD, collectively referred to as chronic respiratory disease (CRDs)) using the COLA-6 questionnaire, are able to access diagnostic testing and treatment.
The investigators will re-assess people diagnosed with abnormal spirometry in the MARES1 study (NCT07050823) or identified as being at high-risk for CRDs in the MARES2 study (NCT07093021). The estimated sample size is 309 from MARES1 and 164 from MARES2 for a total sample size of 473.
Qualitative interviews will be conducted with a diverse subsample of 30 participants to explore their experience accessing CRD diagnosis and treatment, including barriers and facilitators, while all participants will undergo basic data collection and spirometry.
None
No consent to take part in MARES3.
People with a non-communicable disease and found to be at high risk for, or newly diagnosed with a chronic respiratory disease
Case-only
Cross-sectional
Not listed
Barriers and facilitators to accessing care for those with newly diagnosed / suspected chronic respiratory disease in primary healthcare services in Brazil.
Barriers and facilitators to accessing care for those with newly diagnosed / suspected chronic respiratory disease in primary healthcare services in Brazil, assessed at qualitative interviews.
Spirometry
Pre-and post bronchodilator spirometry
Disease Control Questionnaire
Chronic Airways Assessment Test (CAAT) questionnaire
FeNO
Fractional Exhaled Nitric Oxide
Disease Control Questionnaire
ACQ-7 (Asthma Control Questionnaire)
Click on the lead sponsor to view all of their trials.
University College, London
Lead sponsor
Universidade Federal de Sao Carlos
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
